Concepedia

Danielly C. Ferraz da Costa

DC

Statistics

Publications

12

Citations

806

H-Index

11

Active since

2006

Affiliations

Universidade Federal do Rio de Janeiro(Current)

Universidade do Estado do Rio de Janeiro

National Institute of Science and Technology for Structural Biology and Bioimaging

Universidade Estadual de Campinas (UNICAMP)

Danielly C. Ferraz da Costa is an author at Universidade Federal do Rio de Janeiro specializing in pharmacology, oncology, and medicine.

Publications per year

2006–2025

12

Publications

12

Mutant p53 Aggregates into Prion-like Amyloid Oligomers and Fibrils

Ana Paula Dinis Ano Bom, Luciana P. Rangel, Danielly C. Ferraz da Costa et al. · Journal of Biological Chemistry · 2012 · 278 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Activation of Nrf2-Antioxidant Signaling by 1,25-Dihydroxycholecalciferol Prevents Leptin-Induced Oxidative Stress and Inflammation in Human Endothelial Cells

Thaisa M Teixeira, Danielly C. Ferraz da Costa, Ângela Castro Resende et al. · Journal of Nutrition · 2017 · 103 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cells

Luciana P. Rangel, Giulia D. S. Ferretti, Caroline L. Costa et al. · Journal of Biological Chemistry · 2019 · 86 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest

Fabiana Alves Casanova, Julia Quarti, Danielly C. Ferraz da Costa et al. · Journal of Cellular Biochemistry · 2012 · 83 citations

Medicine, Oncology, Pharmacology +16

Resveratrol prevents p53 aggregation <i>in vitro</i> and in breast cancer cells

Danielly C. Ferraz da Costa, Nathali Campos, Ronimara A. Santos et al. · Oncotarget · 2018 · 83 citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 12